Ultrastructural characterization of the Mitochondria-associated membranes abnormalities in human astrocytomas: Functional and therapeutics implications

References

• Giorgi C, Missiroli S, Patergnani S, Duszynski J, Wieckowski MR, Pinton P. Mitochondria-associated membranes: composition, molecular mechanisms, and physiopathological implications. Antioxid Redox Signal. 2015;22:995–1019.
   PubMed Web of Science ®Google Scholar
• Kato H, Nishitoh H. Stress responses from the endoplasmic reticulum in cancer. Front Oncol. 2015 Apr 20;5:93. doi: 10.3389/fonc.2015.00093. eCollection 2015.
   PubMed Web of Science ®Google Scholar
• Betz C, Stracka D, Prescianotto-Baschong C, Frieden M, Demaurex N, Hall MN. mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology. Proc Natl Acad Sci USA. 2013;110:12526–12534.
   PubMed Web of Science ®Google Scholar
• Poston CN, Krishnan SC, Bazemore-Walker CR. In-depth proteomic analysis of mammalian mitochondria-associated membranes (MAM). J Proteomics. 2013;79:219–230.
   PubMed Web of Science ®Google Scholar
• van Vliet AR, Verfaillie T, Agostinis P. New functions of mitochondria associated membranes in cellular signaling. Biochim Biophys Acta. 2014;1843:2253–2262.
   PubMed Web of Science ®Google Scholar
• Csordás G, Renken C, Várnai P, et al. Structural and functional features and significance of the physical linkage between ER and mitochondria. J Cell Biol. 2006;174:915–921.
   PubMed Web of Science ®Google Scholar
• Rizzuto R, Brini M, Murgia M, Pozzan T. Microdomains with high Ca2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria. Science. 1993;262(5134):744–747.
   PubMed Web of Science ®Google Scholar
• Simmen T, Lynes EM, Gesson K, Thomas G .Oxidative protein folding in the endoplasmic reticulum: tight links to the mitochondria-associated membrane (MAM). Biochim Biophys Acta. 2010;1798:1465–1473.
   PubMed Web of Science ®Google Scholar
• Masui K, Cavenee WK, Mischel PS. mTORC2 in the center of cancer metabolic reprogramming. Trends Endocrinol Metab. 2014;25:364–373.
   PubMed Web of Science ®Google Scholar
• Arismendi-Morillo GJ, Castellano-Ramirez AV. Ultrastructural mitochondrial pathology in human astrocytic tumors: potentials implications pro-therapeutics strategies. J Electron Microsc (Tokyo). 2008;57:33–39.
   PubMedGoogle Scholar
• Lathia JD, Mack SC, Mulkearns-Hubert EE, Valentim CL, Rich JN. Cancer stem cells in glioblastoma. Genes Dev. 2015;29:1203–1217.
   PubMed Web of Science ®Google Scholar
• Deighton RF, Le Bihan T, Martin SF, et al. Interactions among mitochondrial proteins altered in glioblastoma. J Neurooncol. 2014;118:247–256.
   PubMed Web of Science ®Google Scholar
• Arismendi-Morillo G. Electron microscopy morphology of the mitochondrial network in gliomas and their vascular microenvironment. Biochim Biophys Acta. 2011;1807:602–608.
   PubMed Web of Science ®Google Scholar
• Arismendi-Morillo G, Hoa NT, Ge L, Jadus MR. Mitochondrial network in glioma’s invadopodia displays an activated state both in situ and in vitro: potential functional implications. Ultrastruct Pathol. 2012;36:409–414.
   PubMed Web of Science ®Google Scholar
• Akhtar K, Bussen W, Scott SP. Cancer stem cells - from initiation to elimination, how far have we reached? Int J Oncol. 2009;34:1491–1503.
   PubMed Web of Science ®Google Scholar
• Liberski PP, Kordek R. Ultrastructural pathology of glial brain tumors revisited: a review. Ultrastruct Pathol. 1997;21:1–31.
   PubMed Web of Science ®Google Scholar
• Zhao YD, Huang Q, Zhang TY, et al. Ultrastructural analysis of glioma stem cells-progenitors. Zhonghua Zhong Liu Za Zhi. 2008;30:663–667.
   PubMedGoogle Scholar
• Yang B, Wang Y, Yang C, et al. The ultrastructural difference between CD133-positive U251 glioma stem cells and normal U251 glioma cells. Ultrastruct Pathol. 2012;36:404–408.
   PubMed Web of Science ®Google Scholar
• Singh L, Nag TC, Kashyap S. Ultrastructural changes of mitochondria in human retinoblastoma: correlation with tumor differentiation and invasiveness. Tumour Biol. 2016;37:5797–5803.
   PubMed Web of Science ®Google Scholar
• Visvader JE, Lindeman GJ. Cancer stem cells: current status and evolving complexities. Cell Stem Cell. 2012;10:717–728.
   PubMed Web of Science ®Google Scholar
• El Habr EA, Adamopoulos C, Levidou G, Saetta AA, Korkolopoulou P, Piperi C. The clinical and prognostic significance of activated AKT-mTOR pathway in human astrocytomas. Neurol Res Int. 2012;2012:454957.
   PubMedGoogle Scholar
• Masui K, Cavenee WK, Mischel PS. mTORC2 and metabolic reprogramming in GBM: at the interface of genetics and environment. Brain Pathol. 2015;25:755–759.
   PubMed Web of Science ®Google Scholar
• Hlobilkova A, Ehrmann J, Sedlakova E, et al. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression? Neoplasma. 2007;54:334–341.
   PubMed Web of Science ®Google Scholar
• Giacomello M, Pellegrini L. The coming of age of the mitochondria-ER contact: a matter of thickness. Cell Death Differ. 2016;23:1417–1427.
   PubMed Web of Science ®Google Scholar
• Naon D, Scorrano L. At the right distance: ER-mitochondria juxtaposition in cell life and death. Biochim Biophys Acta. 2014;1843:2184–2194.
   PubMed Web of Science ®Google Scholar
• Csordás G, Várnai P, Golenár T, et al. Imaging interorganelle contacts and local calcium dynamics at the ER-mitochondrial interface. Mol Cell. 2010;39:121–132.
   PubMed Web of Science ®Google Scholar
• Steinbach J P, Weller M. Mechanisms of apoptosis in CNS tumors: application to theory. Curr. Neurol. Neurosci. Res. 2002;2:246–253.
   PubMedGoogle Scholar
• Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314.
   PubMed Web of Science ®Google Scholar
• Wu Y, Lu Y, Chen W, Fu J, Fan R. In silico experimentation of glioma microenvironment development and anti-tumor therapy. PLoS Comput Biol. 2012;8(2):e1002355. doi: 10.1371/journal.pcbi.1002355.
   PubMed Web of Science ®Google Scholar
• Wegman-Ostrosky T, Reynoso-Noverón N, Mejía-Pérez SI, et al. Clinical prognostic factors in adults with astrocytoma: Historic cohort. Clin Neurol Neurosurg. 2016;146:116–122.
   PubMed Web of Science ®Google Scholar
• Masui K, Shibata N, Cavenee WK, Mischel PS. mTORC2 activity in brain cancer: Extracellular nutrients are required to maintain oncogenic signaling. Bioessays. 2016;38:839–844.
   PubMed Web of Science ®Google Scholar
• Seyfried TN, Flores R, Poff AM, D’Agostino DP, Mukherjee P. Metabolic therapy: a new paradigm for managing malignant brain cancer. Cancer Lett. 2015;356(2 Pt A):289–300.
   PubMed Web of Science ®Google Scholar
• Maroon JC, Seyfried TN, Donohue JP, Bost J. The role of metabolic therapy in treating glioblastoma multiforme. Surg Neurol Int. 2015;6:61. doi: 10.4103/2152-7806.155259. eCollection 2015.
   PubMedGoogle Scholar